nodes	percent_of_prediction	percent_of_DWPC	metapath
Phendimetrazine—Dysuria—Pravastatin—atherosclerosis	0.0165	0.0244	CcSEcCtD
Phendimetrazine—Flushing—Lovastatin—atherosclerosis	0.0155	0.0229	CcSEcCtD
Phendimetrazine—Sweating—Niacin—atherosclerosis	0.0153	0.0226	CcSEcCtD
Phendimetrazine—Flushing—Ezetimibe—atherosclerosis	0.0152	0.0225	CcSEcCtD
Phendimetrazine—Flushing—Simvastatin—atherosclerosis	0.0145	0.0214	CcSEcCtD
Phendimetrazine—Vision blurred—Lovastatin—atherosclerosis	0.0137	0.0203	CcSEcCtD
Phendimetrazine—Tremor—Lovastatin—atherosclerosis	0.0136	0.0201	CcSEcCtD
Phendimetrazine—Flushing—Niacin—atherosclerosis	0.0133	0.0197	CcSEcCtD
Phendimetrazine—Flushing—Pravastatin—atherosclerosis	0.0131	0.0194	CcSEcCtD
Phendimetrazine—Vision blurred—Simvastatin—atherosclerosis	0.0128	0.0189	CcSEcCtD
Phendimetrazine—Tremor—Simvastatin—atherosclerosis	0.0127	0.0188	CcSEcCtD
Phendimetrazine—Insomnia—Rosuvastatin—atherosclerosis	0.0127	0.0187	CcSEcCtD
Phendimetrazine—Palpitations—Ezetimibe—atherosclerosis	0.0126	0.0186	CcSEcCtD
Phendimetrazine—Constipation—Rosuvastatin—atherosclerosis	0.012	0.0177	CcSEcCtD
Phendimetrazine—Vision blurred—Niacin—atherosclerosis	0.0118	0.0174	CcSEcCtD
Phendimetrazine—Vision blurred—Pravastatin—atherosclerosis	0.0116	0.0171	CcSEcCtD
Phendimetrazine—Tremor—Pravastatin—atherosclerosis	0.0115	0.017	CcSEcCtD
Phendimetrazine—Anorexia—Lovastatin—atherosclerosis	0.0113	0.0167	CcSEcCtD
Phendimetrazine—Abdominal pain—Rosuvastatin—atherosclerosis	0.0111	0.0164	CcSEcCtD
Phendimetrazine—Palpitations—Niacin—atherosclerosis	0.011	0.0163	CcSEcCtD
Phendimetrazine—Insomnia—Lovastatin—atherosclerosis	0.0107	0.0159	CcSEcCtD
Phendimetrazine—Anorexia—Simvastatin—atherosclerosis	0.0106	0.0156	CcSEcCtD
Phendimetrazine—Insomnia—Ezetimibe—atherosclerosis	0.0105	0.0156	CcSEcCtD
Phendimetrazine—Decreased appetite—Lovastatin—atherosclerosis	0.0103	0.0152	CcSEcCtD
Phendimetrazine—Constipation—Lovastatin—atherosclerosis	0.0101	0.015	CcSEcCtD
Phendimetrazine—Decreased appetite—Ezetimibe—atherosclerosis	0.0101	0.015	CcSEcCtD
Phendimetrazine—Insomnia—Simvastatin—atherosclerosis	0.01	0.0148	CcSEcCtD
Phendimetrazine—Constipation—Ezetimibe—atherosclerosis	0.00995	0.0147	CcSEcCtD
Phendimetrazine—Tachycardia—Niacin—atherosclerosis	0.00995	0.0147	CcSEcCtD
Phendimetrazine—Hyperhidrosis—Niacin—atherosclerosis	0.00985	0.0146	CcSEcCtD
Phendimetrazine—Anorexia—Niacin—atherosclerosis	0.00972	0.0144	CcSEcCtD
Phendimetrazine—Hyperhidrosis—Pravastatin—atherosclerosis	0.0097	0.0143	CcSEcCtD
Phendimetrazine—Decreased appetite—Simvastatin—atherosclerosis	0.00965	0.0143	CcSEcCtD
Phendimetrazine—Diarrhoea—Rosuvastatin—atherosclerosis	0.00958	0.0142	CcSEcCtD
Phendimetrazine—Anorexia—Pravastatin—atherosclerosis	0.00957	0.0141	CcSEcCtD
Phendimetrazine—Constipation—Simvastatin—atherosclerosis	0.00949	0.014	CcSEcCtD
Phendimetrazine—Abdominal pain—Lovastatin—atherosclerosis	0.00938	0.0139	CcSEcCtD
Phendimetrazine—Dizziness—Rosuvastatin—atherosclerosis	0.00926	0.0137	CcSEcCtD
Phendimetrazine—Insomnia—Niacin—atherosclerosis	0.00922	0.0136	CcSEcCtD
Phendimetrazine—Abdominal pain—Ezetimibe—atherosclerosis	0.0092	0.0136	CcSEcCtD
Phendimetrazine—Insomnia—Pravastatin—atherosclerosis	0.00908	0.0134	CcSEcCtD
Phendimetrazine—Decreased appetite—Niacin—atherosclerosis	0.00886	0.0131	CcSEcCtD
Phendimetrazine—Abdominal pain—Simvastatin—atherosclerosis	0.00877	0.013	CcSEcCtD
Phendimetrazine—Headache—Rosuvastatin—atherosclerosis	0.00877	0.013	CcSEcCtD
Phendimetrazine—Decreased appetite—Pravastatin—atherosclerosis	0.00872	0.0129	CcSEcCtD
Phendimetrazine—Constipation—Pravastatin—atherosclerosis	0.00858	0.0127	CcSEcCtD
Phendimetrazine—Nausea—Rosuvastatin—atherosclerosis	0.00832	0.0123	CcSEcCtD
Phendimetrazine—Diarrhoea—Lovastatin—atherosclerosis	0.00812	0.012	CcSEcCtD
Phendimetrazine—Abdominal pain—Niacin—atherosclerosis	0.00806	0.0119	CcSEcCtD
Phendimetrazine—Diarrhoea—Ezetimibe—atherosclerosis	0.00796	0.0118	CcSEcCtD
Phendimetrazine—Abdominal pain—Pravastatin—atherosclerosis	0.00793	0.0117	CcSEcCtD
Phendimetrazine—Dizziness—Lovastatin—atherosclerosis	0.00785	0.0116	CcSEcCtD
Phendimetrazine—Dizziness—Ezetimibe—atherosclerosis	0.0077	0.0114	CcSEcCtD
Phendimetrazine—Diarrhoea—Simvastatin—atherosclerosis	0.00759	0.0112	CcSEcCtD
Phendimetrazine—Headache—Lovastatin—atherosclerosis	0.00743	0.011	CcSEcCtD
Phendimetrazine—Dizziness—Simvastatin—atherosclerosis	0.00734	0.0108	CcSEcCtD
Phendimetrazine—Headache—Ezetimibe—atherosclerosis	0.00729	0.0108	CcSEcCtD
Phendimetrazine—Nausea—Lovastatin—atherosclerosis	0.00705	0.0104	CcSEcCtD
Phendimetrazine—Diarrhoea—Niacin—atherosclerosis	0.00697	0.0103	CcSEcCtD
Phendimetrazine—Headache—Simvastatin—atherosclerosis	0.00695	0.0103	CcSEcCtD
Phendimetrazine—Nausea—Ezetimibe—atherosclerosis	0.00691	0.0102	CcSEcCtD
Phendimetrazine—Diarrhoea—Pravastatin—atherosclerosis	0.00687	0.0101	CcSEcCtD
Phendimetrazine—Dizziness—Niacin—atherosclerosis	0.00674	0.00996	CcSEcCtD
Phendimetrazine—Dizziness—Pravastatin—atherosclerosis	0.00664	0.00981	CcSEcCtD
Phendimetrazine—Nausea—Simvastatin—atherosclerosis	0.00659	0.00974	CcSEcCtD
Phendimetrazine—Headache—Niacin—atherosclerosis	0.00638	0.00944	CcSEcCtD
Phendimetrazine—Headache—Pravastatin—atherosclerosis	0.00629	0.00929	CcSEcCtD
Phendimetrazine—Nausea—Niacin—atherosclerosis	0.00605	0.00895	CcSEcCtD
Phendimetrazine—Nausea—Pravastatin—atherosclerosis	0.00596	0.00881	CcSEcCtD
Phendimetrazine—ADRA1A—G alpha (q) signalling events—F2—atherosclerosis	0.000648	0.002	CbGpPWpGaD
Phendimetrazine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—EDN1—atherosclerosis	0.00063	0.00195	CbGpPWpGaD
Phendimetrazine—ADRA1B—LPA receptor mediated events—AKT1—atherosclerosis	0.000628	0.00194	CbGpPWpGaD
Phendimetrazine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—atherosclerosis	0.000627	0.00194	CbGpPWpGaD
Phendimetrazine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CCL5—atherosclerosis	0.000625	0.00193	CbGpPWpGaD
Phendimetrazine—SLC6A2—NRF2 pathway—TGFB1—atherosclerosis	0.000605	0.00187	CbGpPWpGaD
Phendimetrazine—SLC6A2—SLC-mediated transmembrane transport—ALB—atherosclerosis	0.000603	0.00186	CbGpPWpGaD
Phendimetrazine—ADRA1B—AMPK Signaling—AKT1—atherosclerosis	0.000591	0.00183	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR ligand binding—EDNRA—atherosclerosis	0.000591	0.00183	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR ligand binding—CCR2—atherosclerosis	0.000591	0.00183	CbGpPWpGaD
Phendimetrazine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—F2—atherosclerosis	0.000579	0.00179	CbGpPWpGaD
Phendimetrazine—SLC6A3—Transmembrane transport of small molecules—PLAT—atherosclerosis	0.000576	0.00178	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR ligand binding—GHRL—atherosclerosis	0.000576	0.00178	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR ligand binding—KNG1—atherosclerosis	0.000569	0.00176	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR ligand binding—AGTR1—atherosclerosis	0.000566	0.00175	CbGpPWpGaD
Phendimetrazine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—EDN1—atherosclerosis	0.000559	0.00173	CbGpPWpGaD
Phendimetrazine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCL5—atherosclerosis	0.000555	0.00172	CbGpPWpGaD
Phendimetrazine—SLC6A2—Transmembrane transport of small molecules—PLG—atherosclerosis	0.000553	0.00171	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—CCL4—atherosclerosis	0.000553	0.00171	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR downstream signaling—UTS2—atherosclerosis	0.000542	0.00168	CbGpPWpGaD
Phendimetrazine—SLC6A3—NRF2 pathway—TGFB1—atherosclerosis	0.000536	0.00166	CbGpPWpGaD
Phendimetrazine—SLC6A3—SLC-mediated transmembrane transport—ALB—atherosclerosis	0.000534	0.00165	CbGpPWpGaD
Phendimetrazine—ADRA1A—AMPK Signaling—AKT1—atherosclerosis	0.000525	0.00162	CbGpPWpGaD
Phendimetrazine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—AGT—atherosclerosis	0.000523	0.00162	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR downstream signaling—CASR—atherosclerosis	0.00052	0.00161	CbGpPWpGaD
Phendimetrazine—SLC6A2—Transmembrane transport of small molecules—HMOX1—atherosclerosis	0.00051	0.00158	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR ligand binding—KNG1—atherosclerosis	0.000505	0.00156	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR ligand binding—AGTR1—atherosclerosis	0.000502	0.00155	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—UTS2—atherosclerosis	0.000492	0.00152	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—CCL4—atherosclerosis	0.000491	0.00152	CbGpPWpGaD
Phendimetrazine—SLC6A3—Transmembrane transport of small molecules—PLG—atherosclerosis	0.00049	0.00151	CbGpPWpGaD
Phendimetrazine—SLC6A2—Transmembrane transport of small molecules—APOB—atherosclerosis	0.000489	0.00151	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR downstream signaling—CNR2—atherosclerosis	0.000483	0.00149	CbGpPWpGaD
Phendimetrazine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—F2—atherosclerosis	0.000483	0.00149	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR downstream signaling—UTS2—atherosclerosis	0.000482	0.00149	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR ligand binding—EDN1—atherosclerosis	0.00048	0.00148	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR ligand binding—CCL5—atherosclerosis	0.000476	0.00147	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—CX3CR1—atherosclerosis	0.000472	0.00146	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—CASR—atherosclerosis	0.000472	0.00146	CbGpPWpGaD
Phendimetrazine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—AGT—atherosclerosis	0.000464	0.00144	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—CX3CL1—atherosclerosis	0.000463	0.00143	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR downstream signaling—CASR—atherosclerosis	0.000462	0.00143	CbGpPWpGaD
Phendimetrazine—SLC6A3—Transmembrane transport of small molecules—HMOX1—atherosclerosis	0.000452	0.0014	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—HRH1—atherosclerosis	0.000451	0.0014	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—CNR2—atherosclerosis	0.000439	0.00136	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—UTS2—atherosclerosis	0.000437	0.00135	CbGpPWpGaD
Phendimetrazine—SLC6A3—Transmembrane transport of small molecules—APOB—atherosclerosis	0.000433	0.00134	CbGpPWpGaD
Phendimetrazine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CCL2—atherosclerosis	0.00043	0.00133	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR downstream signaling—CNR2—atherosclerosis	0.000429	0.00133	CbGpPWpGaD
Phendimetrazine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—F2—atherosclerosis	0.000429	0.00133	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR ligand binding—EDN1—atherosclerosis	0.000426	0.00132	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR ligand binding—CCL5—atherosclerosis	0.000423	0.00131	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—CX3CR1—atherosclerosis	0.000419	0.0013	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—CASR—atherosclerosis	0.000419	0.0013	CbGpPWpGaD
Phendimetrazine—SLC6A2—Transmembrane transport of small molecules—PPARA—atherosclerosis	0.000412	0.00127	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—CX3CL1—atherosclerosis	0.000411	0.00127	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—HRH1—atherosclerosis	0.000401	0.00124	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR ligand binding—AGT—atherosclerosis	0.000398	0.00123	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—CNR2—atherosclerosis	0.00039	0.00121	CbGpPWpGaD
Phendimetrazine—SLC6A2—Transmembrane transport of small molecules—APOA1—atherosclerosis	0.000387	0.0012	CbGpPWpGaD
Phendimetrazine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCL2—atherosclerosis	0.000382	0.00118	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—CCL3—atherosclerosis	0.000377	0.00117	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR downstream signaling—CCR2—atherosclerosis	0.000376	0.00116	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR downstream signaling—EDNRA—atherosclerosis	0.000376	0.00116	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR ligand binding—F2—atherosclerosis	0.000368	0.00114	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR downstream signaling—GHRL—atherosclerosis	0.000366	0.00113	CbGpPWpGaD
Phendimetrazine—SLC6A3—Transmembrane transport of small molecules—PPARA—atherosclerosis	0.000365	0.00113	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—APOA4—atherosclerosis	0.000354	0.0011	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR ligand binding—AGT—atherosclerosis	0.000354	0.00109	CbGpPWpGaD
Phendimetrazine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—atherosclerosis	0.000353	0.00109	CbGpPWpGaD
Phendimetrazine—SLC6A3—Transmembrane transport of small molecules—APOA1—atherosclerosis	0.000343	0.00106	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—CCR2—atherosclerosis	0.000341	0.00106	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—EDNRA—atherosclerosis	0.000341	0.00106	CbGpPWpGaD
Phendimetrazine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCL8—atherosclerosis	0.00034	0.00105	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—CCL3—atherosclerosis	0.000335	0.00104	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR downstream signaling—EDNRA—atherosclerosis	0.000334	0.00103	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR downstream signaling—CCR2—atherosclerosis	0.000334	0.00103	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—GHRL—atherosclerosis	0.000333	0.00103	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR ligand binding—CCL2—atherosclerosis	0.000328	0.00101	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR ligand binding—F2—atherosclerosis	0.000327	0.00101	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—CCL4—atherosclerosis	0.000326	0.00101	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR downstream signaling—GHRL—atherosclerosis	0.000325	0.00101	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR downstream signaling—KNG1—atherosclerosis	0.000322	0.000994	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR downstream signaling—AGTR1—atherosclerosis	0.00032	0.000988	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—APOA4—atherosclerosis	0.000315	0.000973	CbGpPWpGaD
Phendimetrazine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—atherosclerosis	0.000314	0.00097	CbGpPWpGaD
Phendimetrazine—SLC6A2—Transmembrane transport of small molecules—ALB—atherosclerosis	0.000306	0.000947	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—APOA2—atherosclerosis	0.000305	0.000943	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—EDNRA—atherosclerosis	0.000303	0.000938	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—CCR2—atherosclerosis	0.000303	0.000938	CbGpPWpGaD
Phendimetrazine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—atherosclerosis	0.000302	0.000935	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—GHRL—atherosclerosis	0.000295	0.000914	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—KNG1—atherosclerosis	0.000292	0.000903	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR ligand binding—CCL2—atherosclerosis	0.000291	0.0009	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—UTS2—atherosclerosis	0.000291	0.0009	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—AGTR1—atherosclerosis	0.00029	0.000898	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—CCL4—atherosclerosis	0.00029	0.000897	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR downstream signaling—KNG1—atherosclerosis	0.000286	0.000883	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR downstream signaling—AGTR1—atherosclerosis	0.000284	0.000878	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—CX3CR1—atherosclerosis	0.000279	0.000862	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—CASR—atherosclerosis	0.000279	0.000862	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—CX3CL1—atherosclerosis	0.000274	0.000846	CbGpPWpGaD
Phendimetrazine—SLC6A3—Transmembrane transport of small molecules—ALB—atherosclerosis	0.000271	0.000839	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR downstream signaling—EDN1—atherosclerosis	0.000271	0.000838	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—APOA2—atherosclerosis	0.000271	0.000838	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR downstream signaling—CCL5—atherosclerosis	0.000269	0.000831	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—KNG1—atherosclerosis	0.000259	0.000802	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—CNR2—atherosclerosis	0.000259	0.000802	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR ligand binding—CXCL8—atherosclerosis	0.000259	0.000801	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—MMP3—atherosclerosis	0.000259	0.0008	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—UTS2—atherosclerosis	0.000258	0.000799	CbGpPWpGaD
Phendimetrazine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atherosclerosis	0.000258	0.000798	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—AGTR1—atherosclerosis	0.000258	0.000797	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR downstream signaling—PRKCG—atherosclerosis	0.000256	0.00079	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—CX3CR1—atherosclerosis	0.000248	0.000766	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—CASR—atherosclerosis	0.000248	0.000766	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—EDN1—atherosclerosis	0.000246	0.000761	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—CCL5—atherosclerosis	0.000244	0.000755	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—CX3CL1—atherosclerosis	0.000243	0.000751	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR downstream signaling—EDN1—atherosclerosis	0.000241	0.000744	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR downstream signaling—CCL5—atherosclerosis	0.000239	0.000738	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—PRKCG—atherosclerosis	0.000232	0.000718	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—VWF—atherosclerosis	0.000231	0.000715	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—CNR2—atherosclerosis	0.00023	0.000712	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR ligand binding—CXCL8—atherosclerosis	0.00023	0.000712	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—MMP3—atherosclerosis	0.00023	0.000711	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—APOC3—atherosclerosis	0.00023	0.00071	CbGpPWpGaD
Phendimetrazine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atherosclerosis	0.000229	0.000709	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—LDLR—atherosclerosis	0.000228	0.000706	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR downstream signaling—PRKCG—atherosclerosis	0.000227	0.000702	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR downstream signaling—AGT—atherosclerosis	0.000225	0.000695	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—CCL3—atherosclerosis	0.000223	0.000689	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—EDN1—atherosclerosis	0.000219	0.000676	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—CCL5—atherosclerosis	0.000217	0.000671	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—NCF1—atherosclerosis	0.000214	0.00066	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR downstream signaling—F2—atherosclerosis	0.000208	0.000643	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—PRKCG—atherosclerosis	0.000206	0.000638	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—VWF—atherosclerosis	0.000205	0.000635	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—AGT—atherosclerosis	0.000204	0.000632	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—APOC3—atherosclerosis	0.000204	0.000631	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—LDLR—atherosclerosis	0.000203	0.000627	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—EDNRA—atherosclerosis	0.000202	0.000624	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—CCR2—atherosclerosis	0.000202	0.000624	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—CYBA—atherosclerosis	0.000201	0.000621	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR downstream signaling—AGT—atherosclerosis	0.0002	0.000618	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000199	0.000615	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—CCL3—atherosclerosis	0.000198	0.000612	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—GHRL—atherosclerosis	0.000197	0.000608	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—PLAT—atherosclerosis	0.000197	0.000608	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—PARP1—atherosclerosis	0.000197	0.000608	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—NCF1—atherosclerosis	0.00019	0.000586	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—F2—atherosclerosis	0.000189	0.000584	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR downstream signaling—F2—atherosclerosis	0.000185	0.000571	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—AGT—atherosclerosis	0.000181	0.000561	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—PIK3CG—atherosclerosis	0.000181	0.000558	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—CCR2—atherosclerosis	0.000179	0.000554	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—EDNRA—atherosclerosis	0.000179	0.000554	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—CYBA—atherosclerosis	0.000178	0.000551	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000177	0.000546	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—GHRL—atherosclerosis	0.000175	0.00054	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—PARP1—atherosclerosis	0.000175	0.00054	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—PLAT—atherosclerosis	0.000175	0.00054	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—KNG1—atherosclerosis	0.000172	0.000533	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—AGTR1—atherosclerosis	0.000171	0.00053	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—CCL2—atherosclerosis	0.000168	0.00052	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—F2—atherosclerosis	0.000168	0.000518	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—PLG—atherosclerosis	0.000167	0.000517	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—PIK3CG—atherosclerosis	0.00016	0.000496	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—SOCS3—atherosclerosis	0.000158	0.000489	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—KNG1—atherosclerosis	0.000153	0.000474	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—MMP3—atherosclerosis	0.000153	0.000473	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—AGTR1—atherosclerosis	0.000152	0.000471	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—IGF2—atherosclerosis	0.000152	0.00047	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—CCL2—atherosclerosis	0.000149	0.000462	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—PLG—atherosclerosis	0.000148	0.000459	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—APOB—atherosclerosis	0.000148	0.000457	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR downstream signaling—CXCL8—atherosclerosis	0.000146	0.000453	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—EDN1—atherosclerosis	0.000145	0.000449	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—CCL5—atherosclerosis	0.000144	0.000446	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—LPL—atherosclerosis	0.000141	0.000436	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—SOCS3—atherosclerosis	0.000141	0.000435	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—PRKCG—atherosclerosis	0.000137	0.000424	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—MMP3—atherosclerosis	0.000136	0.00042	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—IGF2—atherosclerosis	0.000135	0.000418	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—SPP1—atherosclerosis	0.000134	0.000413	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—CXCL8—atherosclerosis	0.000133	0.000411	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—APOB—atherosclerosis	0.000131	0.000406	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR downstream signaling—CXCL8—atherosclerosis	0.00013	0.000402	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—EDN1—atherosclerosis	0.000129	0.000399	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—CCL5—atherosclerosis	0.000128	0.000396	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—LPL—atherosclerosis	0.000125	0.000387	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—PDGFB—atherosclerosis	0.000124	0.000382	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—PRKCG—atherosclerosis	0.000122	0.000377	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—AGT—atherosclerosis	0.000121	0.000373	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—SPP1—atherosclerosis	0.000119	0.000367	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—APOE—atherosclerosis	0.000118	0.000366	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—LEP—atherosclerosis	0.000118	0.000366	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—CXCL8—atherosclerosis	0.000118	0.000365	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—CAV1—atherosclerosis	0.000117	0.000362	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—APOA1—atherosclerosis	0.000117	0.000361	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—ESR1—atherosclerosis	0.000113	0.000349	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—F2—atherosclerosis	0.000111	0.000345	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—PDGFB—atherosclerosis	0.00011	0.000339	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—AGT—atherosclerosis	0.000107	0.000331	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—PIK3CG—atherosclerosis	0.000107	0.00033	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—LEP—atherosclerosis	0.000105	0.000325	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—APOE—atherosclerosis	0.000105	0.000325	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—CAV1—atherosclerosis	0.000104	0.000322	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—APOA1—atherosclerosis	0.000104	0.000321	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—MAPK3—atherosclerosis	0.000102	0.000316	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—INS—atherosclerosis	0.000101	0.000312	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—ESR1—atherosclerosis	0.0001	0.00031	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—CCL2—atherosclerosis	9.94e-05	0.000307	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—F2—atherosclerosis	9.9e-05	0.000306	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—IGF1—atherosclerosis	9.77e-05	0.000302	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—PIK3CG—atherosclerosis	9.48e-05	0.000293	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—SERPINE1—atherosclerosis	9.28e-05	0.000287	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—MAPK3—atherosclerosis	9.08e-05	0.000281	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—INS—atherosclerosis	8.97e-05	0.000277	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—NOS3—atherosclerosis	8.86e-05	0.000274	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—CCL2—atherosclerosis	8.83e-05	0.000273	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—IGF1—atherosclerosis	8.68e-05	0.000268	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—SERPINE1—atherosclerosis	8.24e-05	0.000255	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—NOS3—atherosclerosis	7.87e-05	0.000243	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—CXCL8—atherosclerosis	7.86e-05	0.000243	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR downstream signaling—AKT1—atherosclerosis	7.59e-05	0.000235	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—IL6—atherosclerosis	7.47e-05	0.000231	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—MMP9—atherosclerosis	7.11e-05	0.00022	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—NFKB1—atherosclerosis	7.03e-05	0.000217	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—CXCL8—atherosclerosis	6.98e-05	0.000216	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—MAPK8—atherosclerosis	6.91e-05	0.000214	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—AKT1—atherosclerosis	6.89e-05	0.000213	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR downstream signaling—AKT1—atherosclerosis	6.74e-05	0.000208	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—IL6—atherosclerosis	6.64e-05	0.000205	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—VEGFA—atherosclerosis	6.38e-05	0.000197	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—STAT3—atherosclerosis	6.32e-05	0.000195	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—MMP9—atherosclerosis	6.31e-05	0.000195	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—NFKB1—atherosclerosis	6.24e-05	0.000193	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—MAPK8—atherosclerosis	6.14e-05	0.00019	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—AKT1—atherosclerosis	6.12e-05	0.000189	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—MAPK3—atherosclerosis	6.04e-05	0.000187	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—TGFB1—atherosclerosis	5.86e-05	0.000181	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—VEGFA—atherosclerosis	5.67e-05	0.000175	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—STAT3—atherosclerosis	5.61e-05	0.000174	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—MAPK3—atherosclerosis	5.36e-05	0.000166	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—TGFB1—atherosclerosis	5.2e-05	0.000161	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—IL6—atherosclerosis	4.41e-05	0.000136	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—AKT1—atherosclerosis	4.07e-05	0.000126	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—IL6—atherosclerosis	3.92e-05	0.000121	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—AKT1—atherosclerosis	3.62e-05	0.000112	CbGpPWpGaD
